PARP inhibitors in prostate cancer: What nurses need to know

Episode 2 February 07, 2022 00:24:43
PARP inhibitors in prostate cancer: What nurses need to know
COR2ED Medical Education
PARP inhibitors in prostate cancer: What nurses need to know

Feb 07 2022 | 00:24:43

/

Show Notes

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria in Malaga in Spain, discuss ‘The potential of PARP inhibitors in prostate cancer: What nurses need to know’. 

In this podcast, the experts discuss PARP inhibitors (PARPi’s), how they work and key data from the registration trials for rucaparib and olaparib, TRITON2 and PROfound.  They also discuss how to select PARPi’s for their prostate cancer patients and where they fit in the overall treatment sequence. Pablo provides some insight into communicating with patients, and the types of questions and concerns they often have in relation to genetic testing and treatment with PARPi’s.  In addition, they also discuss the PARPi’s currently in late-stage development such as niraparib and talazoparib as well as the potential future use of PARPi’s in combination with immunotherapies or androgen receptor pathway inhibitors.

Other Episodes

Episode 1

February 08, 2023 00:29:25
Episode Cover

The physicians’ perspective: Systemic therapy in endometrial carcinoma

Medical education: Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment...

Listen

Episode 1

July 05, 2022 00:21:56
Episode Cover

Timing of ARSI and taxanes for mCSPC

COR2ED Medical Education: Dr. Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr. Neal Shore, Uro-Oncologist and Chief...

Listen

Episode 1

October 06, 2022 00:30:22
Episode Cover

HCC updates from ILCA and ESMO congressess 2022

COR2ED Medical Education: In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of...

Listen